1. 2019
  2. Next-generation muscle-directed gene therapy by in silico vector design

    Sarcar, S., Tulalamba, W., Rincon, M. Y., Tipanee, J., Pham, H. Q., Evens, H., Boon, D., Samara-Kuko, E., Keyaerts, M., Loperfido, M., Berardi, E., Jarmin, S., In't Veld, P., Dickson, G., Lahoutte, T., Sampaolesi, M., De Bleser, P., VandenDriessche, T. & Chuah, M. K., 30 Jan 2019, In : Nature Communications. 10, 1, 18 p., 492.

    Research output: Contribution to journalArticleResearchpeer-review

  3. The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world

    Members of the WFH Gene Therapy Round Table Program Committee and Organizing Committee & VandenDriessche, T., 3 Jan 2019, In : Haemophilia : the official journal of the World Federation of Hemophilia..

    Research output: Contribution to journalScientific reviewResearchpeer-review

  4. 2018
  5. Gene and Cell Therapy: Tearing Down Walls

    VandenDriessche, T., Oct 2018, In : Human Gene Therapy. 29, 10, p. 1071-1073 3 p.

    Research output: Contribution to journalEditorialResearch

  6. Getting Into the Rhythm With CRISPR

    VandenDriessche, T. & Chuah, M. K., 28 Sep 2018, In : Circulation Research. 123, 8, p. 928-930 3 p.

    Research output: Contribution to journalEditorialResearch

  7. A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity

    Chamberlain, K., Riyad, J. M., Garnett, T., Kohlbrenner, E., Mookerjee, A., Elmastour, F., Benard, L., Chen, J., VandenDriessche, T., Chuah, M. K. L., Marian, A. J., Hajjar, R., Gurha, P. & Weber, T., Aug 2018, In : Human Gene Therapy. 29, 8, p. 927-937 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9

    Singh, K., Evens, H., Nair, N., Rincón, M. Y., Sarcar, S., Samara-Kuko, E., Chuah, M. K. & VandenDriessche, T., 2 May 2018, In : Molecular Therapy. 26, 5, p. 1241-1254 14 p.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Biopotency and Efficacy of SHP648, a Next-Generation Fix Gene Therapy Vector

    Weiller, M., Schuster, M., Coulibaly, S., Gritsch, H., Sun, K., VandenDriessche, T., Chuah, M., Rottensteiner, H. & Hoellriegl, W., May 2018, In : Molecular Therapy. 26, 5, p. 375-375

    Research output: Contribution to journalMeeting abstract (Journal)Research

  10. Identification of New Muscle-Tropic Adeno-Associated Virus (AAV) Capsids for Treatment of Rare Hereditary Muscular Disorders

    El Andari, J., Tulalamba, W., Weinmann, J., VandenDriessche, T., Chuah, M. & Grimm, D., May 2018, In : Molecular Therapy. 26, 5, p. 43-44

    Research output: Contribution to journalMeeting abstract (Journal)Research

  11. Optimized liver-specific expression systems for FVIII and FIX (VUB-067-US)

    VandenDriessche, T. & Chuah, M., 15 Mar 2018, Patent No. US 2018/0071406 A1

    Research output: PatentResearch

  12. Optimized liver-specific expression systems for FVIII and FIX (VUB-067-EP)

    VandenDriessche, T. & Chuah, M., 24 Jan 2018, Patent No. EP3270944

    Research output: PatentResearch

Previous 1 2 3 4 5 6 7 8 ...23 Next

ID: 164586